Anticoagulant-associated heavy menstrual bleeding (HMB) is an under-recognised but not uncommon problem in clinical practice. Premenopausal women should be advised of the potential effect of anticoagulant therapy on menstrual bleeding at the time of treatment initiation, and consequences of HMB should be assessed and treated on an ongoing basis. This paper covers treating heavy menstrual bleeding associated with anticoagulants.
Resources
This link is located on another server. The site contains information that has been created, published, maintained, or posted by institutions or organisations independent of the PCWHF.
We do not endorse, approve, certify, or control any linked websites, their sponsors, or any of their policies, activities, products, or services. We do not assume responsibility for the accuracy, completeness, or timeliness of the information.
Visitors to any linked websites should not use or rely on the information contained therein.
Please click “Continue” to leave this website and proceed to the selected site.